It has been shown that progesterone may actively participate in the regulation of blood pressure and other cardiovascular regulations. However, the precise mechanism underlying its effects is unclear. Methods: In the present study, we examined the effects of progesterone on membrane fluidity of erythrocytes in healthy volunteers by means of an electron paramagnetic resonance (EPR) and spin-labeling method. Results: In an in vitro study, progesterone significantly decreased the order parameter (S) for 5-nitroxide stearate (5-NS) and the peak height ratio (ho/h-1) for 16-NS obtained from EPR spectra of erythrocyte membranes. The finding indicates that progesterone might increase the membrane fluidity and improve the membrane microviscosity of erythrocytes. The effect of progesterone was significantly potentiated by the nitric oxide (NO) donor, S-nitroso-N-acetylpenicillamine (SNAP) and a cyclic guanosine monophosphate
I
n postmenopausal women, the production of ovarian hormones such as estrogen and progesterone is markedly reduced with a concomitant increase in cardiovascular events. 1, 2 Many studies have focused on the cardioprotective effects attributable to estrogen. It has been shown that estrogen may induce a vasodilation to some extent by the releasing effect of the nitric oxide (NO) from endothelium, 3 inhibit cardiac fibroblast growth, 4 and have a beneficial effect in rheological properties by improving the membrane microviscosity of erythrocytes. 5 On the other hand, accumulating evidence suggests that progesterone, independently of estrogen, may actively participate in the regulation of blood pressure (BP) and other cardiovascular regulations. Rylance et al 6 reported on the antihypertensive action of progesterone, and other investigators also demonstrated that progesterone lowered BP in humans, 7 and that it blunted the pressor responses to angiotensin II in pregnancy. 8 Recently, Barbagallo et al 9 showed that progesterone inhibited the agonist-induced vasoconstriction by modulating the L-type of calcium channels. However, precise mechanisms underlying the cardioprotective effects of progesterone are still unclear. It has been proposed that cell membrane abnormalities may be linked to cardiovascular diseases including hypertension and stroke. 10, 11 An electron paramagnetic resonance (EPR) and spin-labeling method has been developed to elucidate the membrane fluidity and perturbations of the membrane function by external agents. 12 The membrane fluidity is a physicochemical feature of biomembranes, and is an important factor in modulating the cell rheological behavior. 13 Recently, it has been shown that NO may actively participate in the regulation of membrane properties. 14, 15 Using the EPR method, we have already demonstrated that estrogen increased membrane fluidity and improved membrane microviscosity of erythrocytes by an NO-dependent mechanism, which might indicate that estrogen and NO could have a beneficial effect on rheological behavior of erythrocytes and microcirculation. 5, 16 In the present study, to gain the knowledge regarding the regulatory mechanism of progesterone on the membrane function, we investigated the effects of progesterone on membrane fluidity of erythrocytes and explored a possible link between progesterone and NO by means of the EPR and spin-labeling method.
Methods

Subjects
To investigate the effects of progesterone on the membrane fluidity in vitro, the erythrocytes were obtained from healthy volunteers (n ϭ 31, 19 men, 12 women; aged 50.2 Ϯ 3.1 years (mean Ϯ SEM); BP 128.0 Ϯ 3.3/75.8 Ϯ 2.4 mm Hg; heart rate 73.5 Ϯ 1.6 beats/min; body mass index 23.3 Ϯ 0.6 kg/m 2 ). Informed consent was obtained from all volunteers.
Drugs
Progesterone was obtained from Sigma Chemical Co. (St. Louis, MO). The spin label agents, 5-DOXYL stearate and 16-DOXYL stearate, were purchased from Aldrich Co., Ltd. (Milwaukee, WI). The NO donor, S-nitroso-Nacetylpenicillamine (SNAP), and the cyclic guanosine 3Ј,5Ј-monophosphate (cGMP) analogue, 8-bromo-cGMP, as well as the NO synthase inhibitors, N G -nitro-L-argininemethyl-ester (L-NAME) and asymmetric dimethyl-L-arginine (ADMA), were obtained from Funakoshi Co., Ltd. (Tokyo, Japan). All other drugs were standard laboratory reagents of analytical grade.
Effects of Progesterone Alone on Membrane Fluidity of Erythrocytes In Vitro
Blood samples were obtained by venipuncture after a minimum of 30 min of bed rest while fasting. We used heparin as the anticoagulant (10 L of heparin/10 mL of blood). The plasma and buffy coat were carefully removed by centrifugation at 155 g for 10 min at 4°C. Then, the sedimentated erythrocytes were resuspended in the isotonic buffer (140 mmol/L NaCl, 20 mmol/L Tris-HCl at pH 7.4). The erythrocyte solution was centrifuged at 155 g for 10 min at 4°C. This procedure was repeated three times, and the washed erythrocytes were obtained. The washed erythrocytes were resuspended in the NaCl-Tris buffer at a hematocrit of 50%. [17] [18] [19] [20] The erythrocyte suspension (erythrocytes 100 L and NaCl-Tris buffer 100 L:200 L total) was incubated for 2 hours at 37°C with the NaCl-Tris buffer (100 L) containing progesterone ( Ϫ5 mol/L) was added to the erythrocyte suspension (300 L). The spin-label agents were dissolved and kept at a stock solution of 0.01 mol/L in ethanol as previously described. 21 The agents were diluted in the NaCl-Tris buffer before the experiment (5 ϫ 10 Ϫ5 mol/ L). 21 The mixed solution was then incubated for 2 h at 37°C with gentle shaking, and the EPR measurements were performed. In addition, we examined the effects of a biologically inactive sex hormone, 17␣-estradiol (1 ϫ 10 Ϫ7 to 1 ϫ 10
Ϫ5
mol/L), on membrane fluidity of erythrocytes according to the same procedure as that of progesterone.
Effects of Progesterone in Combination With SNAP, 8-bromo-cGMP, L-NAME or ADMA on Membrane Fluidity of Erythrocytes
To examine the effects of progesterone in combination with the NO donor and cGMP, erythrocytes (100 L) were pretreated with the same volume of the NaCl-Tris buffer containing SNAP (5 ϫ 10 Ϫ6 mol/L) or a cGMP analogue, 8-bromo-cGMP (1 ϫ 10 Ϫ6 mol/L), before the application of progesterone (1 ϫ 10 Ϫ9 to 1 ϫ 10 Ϫ6 mol/L). To examine the effects of the NO synthase inhibitors, erythrocytes (100 L) were pretreated with the same volume of the NaCl-Tris buffer containing L-NAME (1 ϫ 10
Ϫ4 mol/L) before the application of progesterone (1 ϫ 10 Ϫ9 to 1 ϫ 10 Ϫ6 mol/L). The control experiment was performed with vehicle (the NaCl-Tris buffer alone). After a 2-h incubation with 100 L of progesterone (1 ϫ 10 Ϫ9 to 1 ϫ 10 Ϫ6 mol/L) at 37°C, 100 L of the solution containing fatty acid spin-label agents (5-DOXYL stearate and16-DOXYL stearate, 5 ϫ 10 Ϫ5 mol/L) was added to the erythrocyte suspension (300 L). The remainder of the experiment was performed as mentioned previously.
EPR Measurements of Erythrocytes
The EPR measurements were performed using an EPR spectrometer (model Jeol JES-FE2XG, Nihon Denshi, Tokyo, Japan) with a microwave unit (model Jeol ES-SCXA, Nihon Denshi). 5, 14, 21 The microwave power was 5 mW, and the modulation frequency was 100 KHz with a modulation amplitude of 2.0 gauss (G). The temperature of the measurement was controlled at 30°C. The receiver scan width was 3280 Ϯ 50 G with a sweep time of 8 min, and receiver gain was 4.0 ϫ 10 3 to 7.9 ϫ 10 3 with a response time of 1.0 sec.
The fatty acid spin-label agents (5-DOXYL stearate and 16-DOXYL stearate) are believed to be anchored at the lipid-aqueous interface of the cell membranes by their carboxyl ends, whereas the nitroxide group moves rapidly through a restrict angle around the point of attachment. 17, 18 Therefore, the EPR spectra of the fatty acid spin-label agents are used to detect an alteration in the freedom of motion in biological membranes and to provide an indication of membrane fluidity. 17, 18 In addition, 5-DOXYL stearate could be an example of the properties of superficial membrane layers, whereas 16-DOXYL stearate could be an indicator referring to more hydrophobic core of the lipid membranes. For indexes of membrane fluidity, we have evaluated the values of outer and inner hyperfine splitting (2TЈ Љ and 2TЈЌ in G, respectively) in the EPR spectra for 5-DOXYL stearate and calculated the order parameter (S) from 2TЈ Љ and 2TЈЌ. 5, 14, 17, 21, 22 In the EPR spectra for 16-DOXYL stearate, we used the peak height ratio (ho/h-1) value for an index of the membrane fluidity. 5, 14, 17, 21, 22 The greater the values of the order parameter (S) and the peak height ratio (ho/h-1), the lesser the freedom of motion of the spin labels in the biomembrane bilayers indicating the lower membrane fluidity. 5, 14, 17, 21, 22 
Statistics
Values are expressed as mean Ϯ SEM. The differences between the means of the drug treatment and their corresponding controls were tested with a one-way analysis of variance (ANOVA). To compare the means of the different study groups, the Wilcoxon signed rank-sum test was used. A P value Ͻ .05 was accepted as the level of significance. 
Results
Effects of Progesterone Alone on Membrane Fluidity of Erythrocytes in Healthy Volunteers In Vitro
Progesterone (1 ϫ 10 Ϫ9 to 1 ϫ 10 Ϫ6 mol/L) decreased the order parameter (S) for 5-NS and the peak height ratio (ho/h-1) for 16-NS obtained from erythrocyte membranes in normotensive volunteers (n ϭ 31, 19 men, 12 women) in a dose-dependent manner (Table 1 ). This finding shows that progesterone increased membrane fluidity and improved membrane microviscosity of erythrocytes. There was no difference of the progesterone effects between men and women.
On the other hand, 17␣-estradiol, a biologically inactive sex hormone, showed no significant effects of mem- 
Effects of Progesterone in Combination With SNAP or 8-bromo-cGMP on Membrane Fluidity of Erythrocytes
In preliminary experiments, significant effects of SNAP and 8-bromo-cGMP on membrane fluidity were observed at the concentrations greater than 5 ϫ 10 Ϫ5 mol/L and 1 ϫ 10
Ϫ5
mol/L, respectively (data not shown), but were not observed at the concentrations used in the experiments shown in Figs. 1 and 2 (5 ϫ 10 Ϫ6 mol/L and 1 ϫ 10 Ϫ6 mol/L, respectively). In the present experiment, it was clearly demonstrated that the effect of progesterone on the fluidity was significantly potentiated by a low concentration of SNAP (5 ϫ 10 Ϫ6 mol/L), which showed no effects of its own (Fig. 1) .
Similarly, the effect of progesterone on the fluidity was significantly enhanced in the presence of a low concentration of the cGMP analogue 8-bromo-cGMP (1 ϫ 10 Ϫ6 mol/L), although this concentration of 8-bromo-cGMP alone showed no significant effects on the membrane fluidity of its own (Fig. 2) . Fig. 3 showed the effects of progesterone on the membrane fluidity of erythrocytes in the presence of L-NAME (1 ϫ 10 Ϫ5 mol/L). The effect of progesterone was significantly attenuated in the presence of L-NAME. Similarly, ADMA (1 ϫ 10 Ϫ4 mol/L) significantly counteracted the progesterone-induced changes in membrane fluidity of erythrocytes (Fig. 4) .
Effects of Progesterone in Combination With L-NAME and ADMA on Membrane Fluidity of Erythrocytes
Discussion
Many studies have shown that progesterone, independently of estrogen, may actively participate in the regula- tion of BP and other cardiovascular regulations. 6 -9 However, the precise mechanisms underlying the cardioprotective effects of progesterone are not fully understood. In the present study, we investigated the effects of progesterone on membrane fluidity of erythrocytes in healthy volunteers by means of the EPR and spin-labeling method. We showed that progesterone dose dependently decreased the order parameter (S) for 5-DOXYL stearate and the peak height ratio (ho/h-1) for 16-DOXYL stearate obtained from EPR spectra of erythrocyte membranes. The finding indicated that progesterone significantly increased membrane fluidity of erythrocytes and ameliorated the rigidity of the cell membranes. In an in vivo study, Rosenson et al 23 have shown that hormone replacement therapy improved plasma viscosity and rheological properties in postmenopausal women. Because the deformability and microviscosity of erythrocyte membranes may be highly dependent on the membrane fluidity, the reduction in membrane fluidity could cause a disturbance in the blood rheological behavior and in microcirculation, which might contribute to the pathophysiology of cardiovascular diseases such as hypertension. 13, 14, 22 It would be possible that the membrane action of progesterone could be one of the mechanisms responsible for its beneficial effects in improving the rheological behavior of erythrocyte membranes.
In this study, we used a concentration range of 10 Ϫ9 to 10 Ϫ6 mol/L for progesterone. It was shown that the circulating level of progesterone may reach 100 to 150 ng/mL (ϳ10 Ϫ6 mol/L), 9 which might be similar to the concentrations used in our in vitro system. In this study, membrane fluidity of erythrocytes was measured after a 2-h incubation with progesterone and after a 2-h incubation with spin-probe and steroid, because Morrill et al 24 have already reported that the effect of progesterone on membrane fluidity reached a maximum level at about 2 to 6 h after initial treatment with steroid in amphibian oocytes. Membrane fluidity is a physicochemical feature of biomembranes, which might be influenced by the interactions with cytoskeletal proteins. 25, 26 A longer response time with progesterone would be necessary to evaluate the changes in membrane fluidity. The lack of an energy source for a lengthy incubation would deplete adenosine triphosphate (ATP) and influence the membrane function. However, it was shown that glucose alone might increase the intracellular calcium content, 27 and we used the isotonic NaCl-Tris buffer without glucose in this study.
It is well recognized that signal transduction induced by steroid hormones is mediated through intranucleus receptors (genomic receptors). Recently, it has also been shown that nongenomic steroid hormone receptors are present on the plasma membranes. 28 -30 Kaya and Saito 31 reported a significant effect of progesterone on the morphology of human erythrocytes by using scanning electron microscopy. Waddell and Bruce 32 observed the uptake of progesterone by erythrocytes in the rat, and demonstrated that almost 10% of plasma progesterone was located within the erythrocyte fraction. It was also reported that when eryth- rocytes were incubated with sex hormones such as estrogen in vitro, two-thirds were bound to the membranes, whereas one-third was in the soluble fraction. 33 Puca and Sica 34 provided evidence for the existence of specific and high-affinity binding components to estrogen in the cytoskeletal matrix of the erythrocyte membranes. We have examined the effects of a biologically inactive sex hormone, 17␣-estradiol, which showed no significant effects on membrane fluidity of erythrocytes. However, it is still uncertain whether erythrocytes might bear the specific receptors for sex hormones, and the nonspecific action of progesterone cannot be excluded.
In the present study, it was clearly shown that the effect of progesterone was significantly potentiated by a low concentration of SNAP, an NO donor, and a cGMPanalogue, 8-bromo-cGMP, which have no effects alone. These synergistic effects suggest that the action of progesterone might be, at least in part, mediated by the NO-and cGMP-related pathways. The hypothesis was confirmed by the finding that the effects of progesterone were blocked by L-NAME and ADMA, the NO synthase (NOS) inhibitors. NO is a potent stimulator of guanylate cyclase activity and is produced by different isoforms of NOS. 35 Jubelin and Gierman 36 showed that erythrocytes of rats and humans are positive for NOS, which indicated that erythrocytes possess all the cellular machinery to synthesize their own NO. They proposed that erythrocytes would synthesize and use NO to modulate their own physiology. We also reported that NO might have a crucial role in the regulation of membrane fluidity of erythrocytes.
14 Rupnow et al 37 showed that progesterone and estrogen alone and in combination significantly increased the endothelium NOS expression in uterine artery endothelium. It was also demonstrated that synergistic action of progesterone and NO might be necessary during the establishment of pregnancy. 38 These previous findings coupled with our present result suggest that NO might play a role in progesterone-induced alterations in plasma membrane properties. On the other hand, Whiting et al 19 reported that progesterone decreased the lipid fluidity of phosphatidylcholine liposomes, synaptosomal plasma membranes, and sarcoplastic reticulum membranes. It was also shown that progesterone decreased membrane fluidity of the amphibian oocyte plasma membranes. 24 The precise reason responsible for the discrepancy between these results and ours is unclear. The difference might be partially due to the tissues or species used, 19, 24 or experimental method. 19 Barbagallo et al 9 demonstrated the vascular effect of progesterone and proposed that the vasodilatory effect of progesterone may, at least in part, be mediated by modulation of intracellular calcium mobilization. Further studies should be conducted to assess more thoroughly the relationships between progesterone and the cellular signal transduction system and their contribution to membrane function.
In summary, the results of the present study showed that progesterone increased membrane fluidity of erythrocytes in healthy volunteers. The effects were mediated, to some extent at least, by the NO-and cGMP-dependent pathways. Our data also indicate that progesterone may have a crucial modulatory action on erythrocyte membrane fluidity, which may also be of considerable biological and clinical significance in determining rheological properties of the membranes, and further suggest that progesterone could have a beneficial effect on erythrocyte membrane function in humans.
